IJMDC. 2019; 3(10): 1-5

Telogen effluvium: a review

Authors: Moteb Khalaf Alotaibi.

ABSTRACT

Hair loss is a common clinical presentation in medical practice. Telogen effluvium is considered one among the most prevalent causes of hair loss, particularly in female patients. Telogen effluvium could be associated with significant psychosocial comorbidities, thus result in difficulty in administering proper medical treatment. An electronic literature search was performed using the PubMed and Google Scholar databases to identify relevant articles published between 1993 and 2017 on telogen effluvium. Search keywords included “telogen effluvium” and “hair loss.” The study team included studies published in English. Editorials, brief notes, conference proceedings, and letters to editors were excluded. A total of 18 articles were selected and reviewed for epidemiology, etiopathogenesis, clinical presentation, and management of telogen effluvium. Telogen effluvium was found to be a common cause of diffuse hair loss. Studies agreed to the fact that diagnosis could represent a clinical challenge and management may be unsatisfactory to the majority of the patients.

Keywords:
Telogen effluvium, hair loss, hair fall, alopecia.


View PDF
Telogen effluvium: a review


Authors
Moteb Khalaf Alotaibi
Department of Medicine, Unit of Dermatology, Unaizah College of Medicine, Qassim University, Qassim, Saudi Arabia.
PubMed articlesGoogle scholar articles


Correspondence to:
. Department of Medicine, Unit of Dermatology, Unaizah College of Medicine, Qassim University, Qassim, Saudi Arabia.; Moteb.alotaibi@ucm.edu.sa

Publication history
Received 12 Dec 2018
Accepted 18 Jun 2019
Published online 11 Sep 2019
Published in print 26 Sep 2019

How to cite this article?

Export to EndNote Export to refMan

Pubmed Style

Moteb Khalaf Alotaibi. Telogen effluvium: a review. IJMDC. 2019; 3(10): 1-5. doi:10.24911/IJMDC.51-1544654026


Web Style

Moteb Khalaf Alotaibi. Telogen effluvium: a review. http://www.ijmdc.com/?mno=19095 [Access: October 18, 2019]. doi:10.24911/IJMDC.51-1544654026


AMA (American Medical Association) Style

Moteb Khalaf Alotaibi. Telogen effluvium: a review. IJMDC. 2019; 3(10): 1-5. doi:10.24911/IJMDC.51-1544654026


Vancouver/ICMJE Style

Moteb Khalaf Alotaibi. Telogen effluvium: a review. IJMDC. (2019), [cited October 18, 2019]; 3(10): 1-5. doi:10.24911/IJMDC.51-1544654026


Harvard Style

Moteb Khalaf Alotaibi (2019) Telogen effluvium: a review. IJMDC, 3 (10), 1-5. doi:10.24911/IJMDC.51-1544654026


Turabian Style

Moteb Khalaf Alotaibi. 2019. Telogen effluvium: a review. International Journal of Medicine in Developing Countries, 3 (10), 1-5. doi:10.24911/IJMDC.51-1544654026


Chicago Style

Moteb Khalaf Alotaibi. "Telogen effluvium: a review." International Journal of Medicine in Developing Countries 3 (2019), 1-5. doi:10.24911/IJMDC.51-1544654026


MLA (The Modern Language Association) Style

Moteb Khalaf Alotaibi. "Telogen effluvium: a review." International Journal of Medicine in Developing Countries 3.10 (2019), 1-5. Print. doi:10.24911/IJMDC.51-1544654026


APA (American Psychological Association) Style

Moteb Khalaf Alotaibi (2019) Telogen effluvium: a review. International Journal of Medicine in Developing Countries, 3 (10), 1-5. doi:10.24911/IJMDC.51-1544654026


Share this article

Click the icon of the social media platform on which you would like to share this article.

Article Statistics

Viewed: 1469
Downloaded: 49
Cited: 0

Request permissions

If you wish to reuse any part or all of this article please contact the copyright holder, contact@ejmcr.com.

Copyright © 2018 Discover Publishing Group. All Rights Reserved.